316 related articles for article (PubMed ID: 24360074)
21. Low molecular weight heparin protection against oxalate-induced oxidative renal insult.
Rajeswari A; Varalakshmi P
Clin Chim Acta; 2006 Aug; 370(1-2):108-14. PubMed ID: 16516183
[TBL] [Abstract][Full Text] [Related]
22. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
[TBL] [Abstract][Full Text] [Related]
23. Re: Stewart et al.: stone size limits the use of hounsfield units for prediction of calcium oxalate stone composition (Urology 2015;85:292-295).
Williams JC
Urology; 2015 Apr; 85(4):965. PubMed ID: 25817125
[No Abstract] [Full Text] [Related]
24. [Future perspective on the prevention of nephrolithiasis].
Kohjimoto Y; Shinka T; Morimoto S; Nishihata M
Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
[TBL] [Abstract][Full Text] [Related]
25. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants.
Thamilselvan S; Khan SR; Menon M
Urol Res; 2003 Mar; 31(1):3-9. PubMed ID: 12624656
[TBL] [Abstract][Full Text] [Related]
26. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
[TBL] [Abstract][Full Text] [Related]
27. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
28. Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol.
Huang HS; Ma MC; Chen J; Chen CF
J Urol; 2002 Jun; 167(6):2584-93. PubMed ID: 11992092
[TBL] [Abstract][Full Text] [Related]
29. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
30. Serum antioxidant enzyme levels are decreased in patients with urinary calcium oxalate stones.
Cakir OO; Culha MG; Arisan S; Arisan ED; Altin M; Ward S; Zengi O; Ergenekon E
Urol J; 2017 Jul; 14(4):4015-4019. PubMed ID: 28670668
[TBL] [Abstract][Full Text] [Related]
31. Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.
Schwille PO; Manoharan M; Schmiedl A
Clin Chem Lab Med; 2005; 43(6):590-600. PubMed ID: 16006254
[TBL] [Abstract][Full Text] [Related]
32. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
[TBL] [Abstract][Full Text] [Related]
33. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats.
Green ML; Freel RW; Hatch M
Kidney Int; 2005 Dec; 68(6):2629-38. PubMed ID: 16316339
[TBL] [Abstract][Full Text] [Related]
34. [State of acute phase markers and oxidative stress in patients with kidney stones in the urinary tract].
Carrasco-Valiente J; Anglada-Curado FJ; Aguilar-Melero P; González-Ojeda R; Muntané-Relat J; Padillo-Ruiz FJ; Requena-Tapia MJ
Actas Urol Esp; 2012 May; 36(5):296-301. PubMed ID: 22301017
[TBL] [Abstract][Full Text] [Related]
35. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
36. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
[TBL] [Abstract][Full Text] [Related]
37. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region.
Okada A; Hamamoto S; Taguchi K; Unno R; Sugino T; Ando R; Mizuno K; Tozawa K; Kohri K; Yasui T
BMC Urol; 2018 Mar; 18(1):19. PubMed ID: 29530009
[TBL] [Abstract][Full Text] [Related]
38. [Clinical behavior of mixed nucleus reno-ureteral calculi].
Torres Ramírez C; Aguilar Ruiz J; Zuluaga Gömez A; Espuela Orgaz R; del Río Samper S; Martínez Torres J
Arch Esp Urol; 1981; 34(2):101-14. PubMed ID: 7271327
[TBL] [Abstract][Full Text] [Related]
39. [Milk of calcium calculi: a new composition].
García Cuerpo E; Martínez F; Gutiérrez Sanz-Gadea C; Berenguer A; Lovaco F
Actas Urol Esp; 1985; 9(5):445-8. PubMed ID: 3832826
[No Abstract] [Full Text] [Related]
40. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
